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American medical institutions common-
ly solicit donations from wealthy individ-
uals who receive care [1,2]. Physicians are
often encouraged to assist in these pro-
grams because their existing relationships
afford them insights into each patient’s
clinical history, personality, and financial
situation; experience has shown that
physician involvement can increase the
frequency and size of donations [1–3].
These types of development initiatives are
often referred to as ‘‘grateful patient’’
programs, and there are indeed patients
who find joy in giving back to the
clinicians and institutions that have made
a difference in their lives [3].
In the last several years, many institu-
tions have responded to declining reim-
bursement rates and competitive research
grant funding by intensifying their devel-
opment programs [1,4,5]. These newer,
more proactive approaches to identifying
and soliciting potential donors risk blur-
ring the lines between clinical care and
fundraising, pushing the outer limits of
gratitude and comfort for both patients
and physicians. When the US Department
of Health and Human Services (HHS)
updated the Health Insurance Portability
and Accountability Act (HIPAA) Privacy
Rule in January 2013, they shifted the
boundaries of permitted development
activities by including both new protec-
tions for patients and new avenues for
using clinical information for fundraising
purposes. We propose that institutions
voluntarily implement development poli-
cies that limit the use of patient informa-
tion in order to safeguard the trust that
forms the basis of the doctor-patient
relationship.
While our discussion focuses on the
specific example of the US HIPAA Privacy
Rule, we note that the concerns raised in this
article are relevant in other nations as well.
Grateful patient programs also exist in
countries where medical institutions are
privately owned, such as Canada and
Australia. Public health systems like the
UK’s obviate the need for hospital-based
development efforts because all costs are
borne by the government. However, the
universities affiliated with academic health
institutionshavefundraisingprograms,asdo
professional organizations like the Royal
Society of Medicine. In nations like Hun-
gary, the public health system operates
within a well-recognized economy of ‘‘infor-
mal payments’’ to doctors in order to secure
faster or better care, raising many of the
same concerns discussed here in the context
of formal fundraising [6]. We note, however,
that philanthropy from patients is somewhat
less relevant to hospitals that primarily treat
populations of low socioeconomic status.
Background: Ethical Concerns
with Physician Involvement in
Fundraising
Some forms of physician participation
in fundraising are fairly benign. Waiting
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Summary
N American medical institutions commonly have ‘‘grateful patient’’ programs that
solicit donations from wealthy individuals who receive care. Physicians are often
encouraged to assist in these programs.
N Development efforts have intensified in recent years, and the increasing
reliance on physician fundraisers risks blurring the lines between clinical care
and fundraising. New changes to the US Health Insurance Portability and
Accountability Act (HIPAA) Privacy Rule continue that trend by allowing
development officials to access certain types of clinical information without
patient consent.
N The practice of physicians fundraising from their own patients raises three main
concerns: (1) undue pressure on patients to contribute, (2) possible
expectations of preferential treatment from donors, and (3) concerns about
patient confidentiality and trust.
N We propose that institutions voluntarily adopt development policies that
mitigate these risks. Specifically, we recommend that patient consent be
secured before development staff access patient information or physicians refer
patients to the development office. We also recommend that physicians not
directly solicit donations from their own patients.
N The concerns discussed here in the context of American grateful patient
programs are relevant to similar patient fundraising efforts in other nations.
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highlighting fundraising initiatives, and
patients who express interest in giving
may be referred to development personnel.
Many development offices have begun
taking a more proactive approach. Some
have instituted streamlined protocols for
regular wealth screenings of admitted
patients, bedside visits to targeted potential
donors, and VIP ‘‘concierge’’ programs
with special amenities for patients who’ve
given in the past [1,7]. Institutions may
also encourage physicians to notify the
development office of potential donors
among their patients. A 2010 randomized
controlled trial revealed that training
sessions can increase the number of
physician-initiated referrals [2], and insti-
tutions can now hire private consulting
firms that offer professional coaching
services [8]. Some physicians go a step
further and directly engage their patients
in conversations about giving. They may
begin by describing their clinical and
research activities and then identify fund-
ing needs, or they may broach the subject
of giving with wealthy patients who have
recovered from a major procedure [3].
Physician participation in development
activities can create tension between their
roles as caregiver and fundraiser, poten-
tially undermining the trust at the heart of
the doctor-patient relationship. We iden-
tify three main concerns. First, patients
may feel undue pressure to make a
contribution if their caregiver is involved
in making the appeal [4,9]. They may
worry that declining to give will damage
their relationship with their physician or
have an adverse effect on their treatment,
particularly if the physician’s care encom-
passes other family members or life-
threatening conditions.
Second, there is the possibility that
patients who decide to give may harbor
expectations of preferential treatment. VIP
concierge programs offer institutional
comforts like private rooms [1,4,7], but
large donors may hope for clinically
oriented favors from their physician in
the form of last-minute appointments,
longer visits, or largesse with prescription
medications that are not clinically indicat-
ed. Well-intentioned physicians may feel a
desire to reciprocate patients’ generosity,
or feel pressure to accommodate donors’
requests to protect the institution’s finan-
cial interests [7].
Third, there are broader issues of
privacy and trust [9]. Patients may be
disquieted to learn that their physician
assessed their financial situation and
perhaps shared that information with
non-medical staff in the hospital. They
may worry that their doctor sees them as a
purse rather than a person.
A recent qualitative survey found that
many physicians with fundraising experience
are sensitive to these concerns, though some
physicians maintain that there are no ethical
problems with fundraising from patients [7].
Physicians have also noted benefits to
fundraising with their own patients, such as
the increased motivation to provide excellent
care and build strong personal relationships
[3]. However, a physician’s active role in the
financial conversation means there is no
longer a clear dividing line between the
physician as health care provider and
physician as fundraiser.
The American Medical Association
(AMA) takes a hard line: in a 2004
opinion, the AMA Council on Ethical
and Judicial Affairs recommended that
‘‘physicians should avoid directly soliciting
their own patients, especially at the time of
a clinical encounter’’ [9]. The AMA also
noted that preserving patient confidential-
ity may require ‘‘permission from the
patient [to] be obtained prior to divulging
any information to third parties,’’ such as
development officials [9]. Nonetheless,
physicians continue to be actively involved
in development work, often at the urging
of development officials [1–3,7].
The New HIPAA Privacy Rule
In January 2013, the HHS promulgated
significant changes to the HIPAA Privacy
Rule. The new rule covers more entities,
grants patients greater access to their own
information, and expands the govern-
ment’s enforcement authority [10]. Less
attention has been paid to the changed
regulations on using patient information
for fundraising purposes [11]. Some of the
updates bolster patient protections; for
example, we applaud the strengthened
requirement that all development commu-
nications give patients a clear choice to opt
out of future fundraising.
The new regulations also loosen the
restrictions on access to clinical informa-
tion. Formerly, development staff required
a signed patient waiver to view anything
other than basic demographic data, but
they may now freely access three addi-
tional categories of information (45 C.F.R.
1 164.514(f) (2013)) [11]. First, they may
view basic patient outcome information.
We support this change because it allows
fundraising staff to avoid reaching out to
patients who have died or experienced
other severe health consequences.
What we find more troubling is that
development staff may also view
patients’ department of service and treat-
ing physician, which further erodes the
increasingly hazy barrier between clinical
and fundraising activities. This may con-
tribute to more frequent or more assertive
requests from development to both pa-
tients and physicians, thereby heightening
all three of the concerns outlined above.
Development staff may now proactively
point physicians toward specific wealthy
prospects among their patients, pressuring
them to broach the subject of charitable
giving or to personally reach out to patients
with invitations to fundraising events.
Additionally, physicians are now able to
refer patients to development without their
knowledge; under the prior rule, such a
referral required signed patient authoriza-
tion because the identity of the treating
physician was protected information that
would necessarily be disclosed.
Thesenewpossibilitiesraisespecialconcerns
for patient confidentiality and trust. Some
departments and specialists reveal aspects of a
patient’s clinical history by simple association.
Patients may be very sensitive to perceived
invasions of privacy concerning care for
conditions such as HIV, infertility, or mental
health. Irrespective of the type of care, patients
may be uncomfortable with the idea of
physicians or development using information
from clinical visits to support fundraising work
without their knowledge or consent.
Proposal: Voluntary Standards
to Maintain Confidentiality and
Trust
When HHS solicited public recommen-
dations for the new Privacy Rule, it
received many comments arguing that
expanded access to patient information
would ‘‘streamline…fundraising efforts
and ensure that individuals were sent
communications about campaigns that
would be meaningful to their experiences’’
[11]. In the commentary accompanying
the final rule, HHS noted that a ‘‘small
minority of commenters’’ opposed the
change because of ‘‘privacy concerns.’’
We agree with this latter group, and regret
that their warning was not heeded.
As institutions encourage physicians to
identify and engage potential donors
among their patients, it is critical that we
remain cognizant of the risks involved. In
order to safeguard patient confidentiality
and trust, we propose that institutions
voluntarily adopt development policies
that eschew the full depth of information
available without consent under the new
Privacy Rule.
Access to information on patient out-
comes serves the important purpose of
protecting patients and their families at
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physician information, however, is primar-
ily intended to aid targeted fundraising
efforts. We recommend that, as under the
prior Privacy Rule, development staff only
access this information when authorized by
the patient. Similarly, we recommend that
physicians secure consent before referring
one of their patients to development.
Wenote that the risks outlined above may
be present when physicians engage in
fundraising activities of any kind, including
seeking permission to refer a patient to
development. The only way to completely
avoid these risksistoavoidfundraisingatall.
Forphysicianswhochoosetoparticipate,we
support the AMA’s direction that physicians
maintain a clear distinction between their
development work and their clinical duties,
and that they avoid direct solicitations of
their own patients [9]. A strict policy of
handling giving through formal develop-
ment channels would attenuate all three
kinds of risk by dissociating the physician
from the actual financial request.
In countries like the United States,
philanthropy is an important source of
support for academic and clinical programs
and a way for patients to show their
gratitude. We offer these recommendations
to support ethical fundraising efforts that
gather financial support while protecting
patients’ wellbeing and preserving the
integrity of the doctor-patient relationship.
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